Corteva, Inc.
12.45USD
-0.4100 (-3.19%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CTVA.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.11▲ | $0 | 0 | 0 |
| Next quarter | $0.27▲ | $0 | 0 | 0 |
| Current year | $1.11▲ | $0 | 0 | 0 |
| Next year | $1.13▲ | $0 | 0 | 0 |
257 ratings from 36 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Neutral | $90 $15 | Oct 12, 2026 |
| Keybanc | Upgraded from Sector Weight | Overweight | $17 | Oct 7, 2026 |
| JP Morgan | Upgraded from Neutral | Overweight | $83 $19 | Oct 6, 2026 |
| Argus Research | Reiterated | Buy | $91 | Sep 18, 2026 |
| Citigroup | Maintained | Neutral | $86 $91 | Sep 17, 2026 |
| BMO Capital | Maintained | Outperform | $100 $95 | Sep 16, 2026 |
| UBS | Maintained | Neutral | $85 $90 | Sep 16, 2026 |
| RBC Capital | Reiterated | Outperform | $103 | Sep 16, 2026 |
| Keybanc | Initiated | Sector Weight | — | Sep 11, 2026 |
| UBS | Maintained | Neutral | $89 $85 | Aug 18, 2026 |
| UBS | Maintained | Neutral | $86 $89 | Aug 3, 2026 |
| Citigroup | Maintained | Neutral | $85 $86 | Aug 3, 2026 |
| JP Morgan | Maintained | Neutral | $77 $83 | Aug 3, 2026 |
| BMO Capital | Maintained | Outperform | $95 $100 | Aug 3, 2026 |
| Oppenheimer | Maintained | Outperform | $89 $95 | Jul 23, 2026 |
| RBC Capital | Maintained | Outperform | $97 $103 | Jul 21, 2026 |
| B of A Securities | Maintained | Buy | $90 $96 | Jul 20, 2026 |
| Mizuho | Maintained | Outperform | $96 $97 | Jul 14, 2026 |
| Mizuho | Maintained | Outperform | $94 $96 | Jul 2, 2026 |
| Barclays | Maintained | Overweight | $84 $91 | Jun 11, 2026 |
| UBS | Maintained | Neutral | $90 $86 | Jun 9, 2026 |
| Morgan Stanley | Maintained | Overweight | $84 $95 | May 28, 2026 |
| UBS | Maintained | Neutral | $88 $90 | May 7, 2026 |
| Citigroup | Maintained | Neutral | $83 $85 | May 7, 2026 |
| RBC Capital | Maintained | Outperform | $89 $95 | Apr 24, 2026 |
88 filings from 25 insiders · 0 buy / 0 sell over 6m
Officers and directors of CTVA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| TITUS BRIANOfficer, See Remarks | OtherNon-Qualified Stock Option (right-to-buy) | 14.4k | — | — | Oct 1, 2026 |
| TITUS BRIANOfficer, See Remarks | OtherNon-Qualified Stock Option (right-to-buy) | 17.7k | — | — | Oct 1, 2026 |
| TITUS BRIANOfficer, See Remarks | OtherNon-Qualified Stock Option (right-to-buy) | 14.8k | — | — | Oct 1, 2026 |
| TITUS BRIANOfficer, See Remarks | Other | 11.1k | — | — | Oct 1, 2026 |
| TITUS BRIANOfficer, See Remarks | Other | 13.3k | — | — | Oct 1, 2026 |
| KISSAM LUTHER C IVOfficer, Chief Executive Officer | Other | 127.9k | — | — | Oct 1, 2026 |
| Johnson David PaulOfficer, EVP, Chief Financial Officer | Tax | 8.5k | $81.01 | $690k | Sep 16, 2026 |
| Johnson Jennifer AmyOfficer, SVP, Chief Legal Officer | Tax | 446 | $83.39 | $37k | Sep 15, 2026 |
| POLICINSKI CHRISTOPHER JDirector | Grant | 412 | $78.71 | $33k | Jul 31, 2026 |
| GIESSELMAN JANET PLAUTDirector | Grant | 98 | $78.71 | $8k | Jul 31, 2026 |
| NAYYAR NAYAKI RDirector | Grant | 412 | $78.71 | $33k | Jul 31, 2026 |
| KISSAM LUTHER C IVChief Executive Officer | Grant | 24.1k | — | — | Jun 1, 2026 |
| GIESSELMAN JANET PLAUTDirector | Grant | 95 | $81.01 | $8k | Apr 30, 2026 |
| NAYYAR NAYAKI RDirector | Grant | 401 | $81.01 | $33k | Apr 30, 2026 |
| WARD PATRICK JDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| PREETE KERRY JDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| POLICINSKI CHRISTOPHER JDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| LUTZ MARCOS MDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
| PAGE GREGORY RDirector | Grant | 3.9k | — | — | Apr 28, 2026 |
| EVERITT DAVID CDirector | Grant | 2.4k | — | — | Apr 28, 2026 |
No analyst notes on CTVA yet.
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 7 | 2 | 0 | 0 | Buy2.00 |
Members whose judged calls on CTVA have played out most reliably.
No settled calls on CTVA yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice